Masimo (MASI) Change in Account Payables (2009 - 2026)
Masimo's (MASI) quarterly Change in Account Payables came in at -$31.7 million in Q2 2026, down 419.67% year-on-year from $9.9 million in Q2 2025, and down 134.81% quarter-over-quarter from -$13.5 million in Q1 2026.
Masimo (MASI) Change in Account Payables (2009 - 2026) Analysis & Trends
Masimo's Change in Account Payables history runs 18 years deep, the most recent figure standing at -$31.7 million for Q2 2026.
- On a quarterly basis, Change in Account Payables fell 419.67% year-over-year to -$31.7 million in Q2 2026; TTM through Apr 2026 was -$52.7 million, a 528.46% decrease from a year earlier, with the FY2026 full-year figure at -$27.1 million, down 355.66% from the prior year.
- Change in Account Payables retreated to -$31.7 million in Q2 2026 per MASI's latest filing, from -$13.5 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $31.2 million in Q3 2022 and bottomed at -$31.7 million in Q2 2026.
- The 5-year median for Change in Account Payables is -$7.0 million (2024), against an average of -$938500.0.
- Across the five-year window, Change in Account Payables soared 1635.89% in 2022 and plunged 419.67% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at -$9.1 million in 2022, then tumbled by 31.87% to -$12.0 million in 2023, then soared by 210.83% to $13.3 million in 2024, then plunged by 222.56% to -$16.3 million in 2025, then plunged by 94.48% to -$31.7 million in 2026.
- Per Business Quant, the three latest MASI Change in Account Payables figures stand at -$31.7 million (Q2 2026), -$13.5 million (Q1 2026), and -$16.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -31.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -31.70 Mn |
| Apr 4, 2026 | -31.70 Mn |
| Jan 3, 2026 | -13.50 Mn |
| Jan 3, 2026 | -13.50 Mn |
| Sep 27, 2025 | -16.30 Mn |
| Sep 27, 2025 | -16.30 Mn |
| Jun 28, 2025 | 8.80 Mn |
| Jun 28, 2025 | 8.80 Mn |
| Mar 29, 2025 | -6.10 Mn |
| Mar 29, 2025 | -6.10 Mn |
| Dec 28, 2024 | 13.30 Mn |
| Dec 28, 2024 | 13.30 Mn |
| Sep 28, 2024 | 13.90 Mn |
| Sep 28, 2024 | 13.90 Mn |
| Jun 29, 2024 | -8.80 Mn |
| Jun 29, 2024 | -8.80 Mn |
| Mar 30, 2024 | -7.80 Mn |
| Mar 30, 2024 | -7.80 Mn |
| Dec 30, 2023 | -12.00 Mn |
| Dec 30, 2023 | -12.00 Mn |